Advertisements


Amgen"s Repatha "significantly reduced" LDL-C, non-HDL-C in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Amgen"s Repatha Reduces Bad Cholestrol in Type II Diabetes

Amgen's (AMGN) Repatha signi.....»»

Category: smallbizSource: nytJun 25th, 2018

Amgen makes Repatha available in U.S. at 60% reduced price

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows

Just two jabs reverses diabetes even in people who have had the Type 1 form for decades. The causes of Type 1 diabetes can be significantly reversed over several years with just two injections of a common .....»»

Category: europeSource: fortuneJun 21st, 2018

Coffee May Well Reduce the Risk of Type 2 Diabetes

Coffee May Well Reduce the Risk of Type 2 Diabetes A meta-analysis of 30 studies involving more than 10 years of research suggests coffee consumption may cut the risk of developing Ty.....»»

Category: topSource: livetradingnewsNov 28th, 2018

WellCare partners with diabetes-management startup

WellCare of New York has agreed to use Fit4D, a Manhattan-based company that helps people manage their type 2 diabetes. Fit4D offers a team of certified diabetes educators who can connect with... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkNov 26th, 2018

Coffee May Well Reduce the Risk of Type 2Diabetes

Coffee May Well Reduce the Risk of Type 2 Diabetes A meta-analysis of 30 studies involving more than 10 years of research suggests coffee consumption may cut the risk of developing T.....»»

Category: topSource: livetradingnewsNov 26th, 2018

Zafgen"s IND for diabetes treatment placed on hold by FDA

Zafgen Inc. said Monday the Food and Drug Administration ha placed a clinical hold on its investigational new drug application (IND) for the biopharmaceutical company's first U.S. clinical trial of its type 2 .....»»

Category: topSource: marketwatchNov 26th, 2018

PERC mono-Si bi-facial solar cell production to rise in 2019

Some China-based PV makers are shifting their solar cell focus from single-side P-type PERC mono-Si models to bi-facial ones, production for which is expected to increase significantly in 2019, according to industry sources......»»

Category: topSource: digitimesNov 20th, 2018

Amgen reports results from long-term study of Repatha

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

B2Gold Corp. Reports Positive Third Quarter 2018 Results; Quarterly Operating Cash Flows Increase by $101 M (240%) to $143 M on Record Gold Production and Significantly Reduced All-In Sustaining Costs

VANCOUVER, Nov. 6, 2018 /PRNewswire/ - B2Gold Corp. (TSX:BTO, NYSE:BTG, NSX: B2G)) ("B2Gold" o.....»»

Category: earningsSource: benzingaNov 6th, 2018

Repatha list price cut has benefits for Amgen, says Morgan Stanley

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

Why Amgen Is Lowering the Price of Cholesterol Drug Repatha By 60%

Amgen says Repatha sold $2.....»»

Category: europeSource: fortuneOct 25th, 2018

Apple and Samsung fined for deliberately slowing down phones

Italian investigation found software updates ‘significantly reduced performance’, hastening new purchases.....»»

Category: topSource: moneycentralOct 24th, 2018

Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes.....»»

Category: topSource: seekingalphaOct 5th, 2018

Baloxavir marboxil "significantly reduced" time to improvement of flu symptoms

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

Will This FDA Approval Affect Amgen Stock Significantly?

InvestorPlace - Stock Mark.....»»

Category: topSource: investorplaceOct 3rd, 2018

Eli Lilly"s Ultra Rapid Lispro Succeeds in Diabetes Studies

Eli Lilly's (LLY) insulin candidate, Ultra Rapid Lispro, meets primary endpoint of two late- stage studies in type I and type II diabetes patients of non-infer.....»»

Category: dealsSource: nytOct 3rd, 2018

Valeritas V-Go demonstrates benefits compared to MDI therapy for type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

Novo Nordisk: Type 1 Diabetes Treatments To Boost Growth

Novo Nordisk: Type 1 Diabetes Treatments To Boost Growth.....»»

Category: topSource: seekingalphaOct 1st, 2018